Dolat Capital Market's research report on ACC
ACC posted 0.3%/ 20.6%/ 21.0% YoY growth in revenue/ EBITDA/ PAT to Rs35.4 bn/ Rs6.7 bn/ Rs3.6 bn in Q3CY20 led by 0.8% YoY volume growth coupled with 3.8% YoY realization growth (-2.7% QoQ). We expect 5.1%/ 10.5%/ 12.8% revenue/ EBITDA/ APAT CAGR over CY19-22E led by -11.6%/ 12.6%/ 12.2% volume growth and 3.2%/ 1.5%/ 1.0% cement realization growth in CY20E/ CY21E/ CY22E. We increase our revenue/ EBITDA/ PAT estimates by 3.8%/ 8.6%/ 7.4% for CY20E. We broadly maintain CY21E estimates and introduce CY22E. Considering ACC’s healthy cash flow & RoE, net cash position, and 5.9mtpa (17.7% increase) capacity expansion, current valuation of 10.3x/ 8.7x/ 7.3x CY20E/ CY21E/ CY22E EV/EBITDA provides comfort which is 23%/ 35%/ 38% discount to 1yr Fwd EV/EBITDA of 3/ 5/ 10 years.
Outlook
We rollover to Sept’22E vs. Dec’21E. Thus, we maintain BUY with an upward revised TP of Rs1,966 (10x Sept’22E EV/EBITDA).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!